Inhibition of phagocytosis and MLCK activity by myosin adenosine triphosphatase inhibitor BDM.

PMNLs were incubated for 10 minutes at 37°C with the indicated concentrations of BDM, then challenged with EIgG for 30 minutes (phagocytosis) or 5 minutes (MLCK activity). EIgG that were not ingested were hypotonically lysed, and phagocytosis samples were fixed with glutaraldehyde for microscopic quantitation. MLCK activity was measured as described for Figure 1. Data points represent the mean ± SEM of 4 experiments. *Significantly different from control (100%); P < .05. **Significantly different from control (100%); P < .005. ***Significantly different from control (100%); P < .001.